In today’s evolving wellness landscape, the nutraceutical market is shifting from single-condition solutions toward ingredients that can support multiple dimensions of health across different age groups.
This shift is driving demand for botanicals with both clinical depth and functional versatility. Ashwagandha, widely recognized as a Rasayana and an adaptogen, is now being re-examined through this broader lens.
A growing portfolio of randomized, double-blind, placebo-controlled trials suggests that its benefits may extend across age groups, from children to the elderly, with consistent signals of efficacy and, importantly, a strong safety profile.
Attention, memory, and sleep quality in early-life populations
Emerging clinical evidence has begun to explore ashwagandha root extract’s role in younger populations, particularly regarding cognitive performance and daily functioning.
A randomized, double-blind, placebo-controlled study investigated children aged 6 to 12 years with parent-reported concerns related to attention, concentration, and memory. Supplementation with ashwagandha root extract over 8 weeks resulted in significant improvements in multiple cognitive domains.1
These included enhanced memory recall, improved attention accuracy, and better reaction time performance. Sleep quality also improved, as reported by caregivers. Crucially, the ashwagandha was well tolerated, with no serious adverse events reported.1
Stress, sleep, and cognitive function in healthy adults
In adults, the clinical profile of ashwagandha root extract is well established. Several randomized controlled trials have demonstrated its ability to support stress resilience, cognitive performance, sports performance, and emotional wellbeing.2-5
In a 24-week randomized, placebo-controlled trial, ashwagandha supplementation was associated with reductions in serum cortisol levels (body weight and BMI), alongside improvements in perceived stress, food cravings, and quality of life.6
Across these studies, ashwagandha demonstrated a favorable safety profile, with only mild and transient adverse events reported and no serious adverse events observed, supporting its use in long-term wellness strategies.
Healthy aging: Quality of life, sleep, and vitality
At the other end of the age spectrum, ashwagandha’s benefits extend into healthy aging, where the focus shifts toward maintaining independence, vitality, and overall quality of life.
In elderly populations aged 60 years and above, randomized controlled trials have demonstrated improvements in quality-of-life scores, sleep quality, mental alertness, and physical performance measures. These outcomes are particularly relevant in addressing age-related declines in both physical and cognitive domains.7,8
Across studies in the elderly, Ashwagandha supplementation was consistently described as safe and well tolerated, with no serious adverse events reported, further strengthening its positioning as a long-term wellness ingredient.
A consistent safety profile across life stages
One of the most defining aspects of ashwagandha’s clinical profile is the consistency of its safety outcomes.
Across studies conducted in children, adults, women, and elderly populations, supplementation has demonstrated high tolerability, an absence of serious adverse events, and only mild, self-limiting side effects were reported.
A recent 12-month observational study evaluating the long-term administration of ashwagandha root extract in healthy adults demonstrated a favorable safety profile, with no serious adverse events reported and no clinically significant changes observed in liver, renal, thyroid, or hematological parameters.9
This consistency is particularly important in the context of lifelong use, where safety is as critical as efficacy. As ashwagandha transitions from short-term stress support to a daily wellness ingredient, its safety profile becomes a central pillar of its value proposition.
Ashwagandha, supported by robust clinical evidence and a consistent safety profile, is increasingly positioned as a multi-functional ingredient capable of supporting diverse health needs across age groups.
References
- Saxena, A.; et al. A clinical assessment of the therapeutic effects of Ashwagandha root extract on cognitive performance, sleep, and fatigue in children aged 6–12 years. Front. Nutr. 2026;13:1742138.
- Coope, O. C.; et al. Ashwagandha Root Extract Stabilises Physiological Stress Responses in Male and Female Team Sports Athletes During Pre-Season Training. Nutrients. 2026;18(2), 230.
- Kale, S.; et al. Safety and Efficacy of Ashwagandha Root Extract on Cognition, Energy and Mood Problems in Adults: Prospective, Randomized, Placebo-Controlled Study. Journal of psychoactive drugs. 2024;1–13. Advance online publication.
- Salve, J.; et al. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus. 2019;11(12): e6466.
- Chandrasekhar, K..; et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. 2012; Indian J Psychol Med 34, 255-262
- Pakhale, K..; et al. Efficacy and safety of Ashwagandha (Withania somnifera) root extract on stress and weight management in adults: a prospective, randomized, double-blind, placebo-controlled study. Journal of medicine and life. 2025;18(12), 1140–1154.
- Honnutagi, R.; et al. Ashwagandha (Withania somnifera) Root Extract Improves General Health in Elderly Men and Women: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study. Phytotherapy research. 2026. Advance online publication.
- Kelgane, S.B.; et al. Efficacy and Tolerability of Ashwagandha Root Extract in the Elderly for Improvement of General Well-being and Sleep: A Prospective, Randomized, Double-blind, Placebo-controlled Study. Cureus. 2020;12(2): e7083.
- Salve, J.; et al. Safety of 12‐Months Administration of Ashwagandha (Withania somnifera) Standardized Root Extract in Healthy Adults: A Prospective, Observational Study. Phytotherapy Research. 2025.
